<DOC>
	<DOCNO>NCT00506623</DOCNO>
	<brief_summary>This study evaluate pathologic complete response rate pre-operative concurrent chemoradiotherapy capecitabine plus irinotecan resectable rectal cancer</brief_summary>
	<brief_title>Preoperative Chemoradiotherapy With Capecitabine Plus Irinotecan Rectal Cancer</brief_title>
	<detailed_description>This study open-label , single center , nonrandomized phase II study . Daily fraction radiotherapy 1.8 Gy total 45 Gy tumor drain lymph node follow coned-down boost 5.4 Gy tumor deliver concurrently chemotherapy . Chemotherapy start day 1 radiotherapy . Capecitabine administer orally dose 825 mg/m2 twice daily weekday ( Monday Friday ) every week radiotherapy . Irinotecan 40 mg/m2 give intravenously week ( D 1 , 8 , 15 , 22 &amp; 29 ) . Six Â± 2 week completion chemoradiotherapy , curative surgery perform . Post-operative chemotherapy capecitabine give patient 3-6 week surgery . Capecitabine 1,250 mg/m2 twice daily day 1-14 every 21 day administer 18 week .</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Camptothecin</mesh_term>
	<criteria>Histologically confirm adenocarcinoma rectum Distal margin tumor locate 0 8 cm anal verge Tumor must clinically resectable surgery R0 resection must likely ECOG performance status 02 No prior chemotherapy , radiotherapy pelvis , immunotherapy Adequate organ function Patients must sign informed consent Malignant disease rectum adenocarcinoma arise chronic inflammatory bowel disease Any unresected synchronous colon cancer Any distant metastasis Intestinal obstruction impend obstruction , decompress colostomy permit Any previous concurrent malignancy nonmelanoma skin cancer situ cancer uterine cervix Any morbidity situation contraindication chemoradiotherapy Patients history significant gastric small bowel resection , malabsorption syndrome , lack integrity upper gastrointestinal tract may compromise absorption capecitabine Pregnant lactate woman patient childbearing potential practicing adequate contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>Rectal neoplasm</keyword>
	<keyword>Neoadjuvant therapy</keyword>
	<keyword>Radiotherapy</keyword>
	<keyword>Combination chemotherapy</keyword>
	<keyword>Irinotecan</keyword>
	<keyword>Capecitabine</keyword>
</DOC>